Determination of ammonia concentrations in cirrhosis patients-still confusing after all these years?

Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 0

Abstract

By the end of the nineteenth century, ammonia had been identified as the main factor responsible for hepatic encephalopathy syndrome. Ammonia is one of the principal products of hepatic metabolism and high concentrations are toxic to the body. Under physiological conditions, the main way by which the body restricts the blood concentration of ammonia to a nontoxic level is by converting it to urea in the liver via the Krebs cycle. The synthesis of glutamine represents an alternative pathway for ammonia detoxification in cirrhotic patients. Although high concentrations of ammonia have been strongly associated with brain edema, estimates of the strength of the correlation between serum ammonia levels and the severity of hepatic encephalopathy vary. The accuracy of ammonia assays depends on the site of specimen collection, treatment of the specimen and the analytical method used. New methods involving measurement of the partial pressure of ammonia and new noninvasive techniques involving quantification of ammonium in the breath have been described. The purpose of this review is to identify factors that affect serum ammonia levels, from its origin and metabolism to its analysis and interpretation of results in the laboratory. In conclusion, variations in estimates of serum ammonia level and the severity of hepatic encephalopathy arise because of individual differences in ammonia metabolism and differences in the accuracy of analytical methods.

Authors and Affiliations

Claudia Isabel Blanco Vela, Francisco Javier Bosques Padilla

Keywords

Related Articles

Genotype/subgenotype distribution of hepatitis B virus among hemodialysis patients with chronical hepatitis B

Introduction. Hepatitis B virus (HBV) infection in hemodialysis (HD) patients is a major concern, but limited information exists on the HBV genotyping in patients on maintenance HD in Turkey. Aim. To investigate the gen...

Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats

This study examined the possible hepatoprotective effect of aminoguanidine in comparison with silymarin and investigated the possible beneficial effects of the combination of aminoguanidine and silymarin on CCL4-induced...

Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia

Abetalipoproteinemia (ABL), or Bassen-Kornzweig syndrome, is a rare autosomal recessive disorder of lipoprotein metabolism, characterized by fat malabsorption, hypocholesterolemia retinitis pigmentosa, progressive neurop...

Epidemiology of hepatocellular carcinoma in sub-Saharan Africa

Published incidences of hepatocellular carcinoma in the Black population of sub-Saharan Africa underestimate the true incidence of the tumor because of the many instances in which hepatocellular carcinoma is either not d...

Download PDF file
  • EP ID EP78067
  • DOI -
  • Views 114
  • Downloads 0

How To Cite

Claudia Isabel Blanco Vela, Francisco Javier Bosques Padilla (2011). Determination of ammonia concentrations in cirrhosis patients-still confusing after all these years?. Annals of Hepatology, 10(0), 60-65. https://europub.co.uk/articles/-A-78067